Latest News
Two medicines are as good as current three-medicine combinations to treat children living with HIV
Results from the D3 (Penta 21) trial presented at CROI show that using dolutegravir and lamivudine is safe and as effective as using a combination of three HIV medicines, to keep the virus under control.
MRC Clinical Trials Unit at UCL to become the UCL Innovative Clinical Trials Unit from April 2026
The Innovative Clinical Trials Unit is committed to fulfilling the mission of smarter studies and global impact, leading to better health.
NeoSep1 Part 1 study shows promising antibiotic options for newborns with suspected sepsis
New results found that off-patent antibiotics fosfomycin and flomoxef were safe in newborn babies with suspected sepsis.